Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New injection could ease jaw pain better than standard treatment

NCT ID NCT07075276

First seen Nov 01, 2025 · Last updated Jun 21, 2026 · Updated 31 times

Summary

This study compares a new injection of liquid phase concentrated growth factor (LPCGF) to standard arthrocentesis (joint washing) for people with painful jaw clicking and limited mouth opening due to a displaced disc. Thirty-two adults aged 18-45 with unilateral disc displacement will be randomly assigned to one of the two procedures. The goal is to see if LPCGF reduces pain and improves mouth opening more than the conventional treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TEMPOROMANDIBULAR DISORDERS (TMD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Faculty of Dentistry- Horus University in Egypt

    RECRUITING

    Damietta, New Damietta, 34518, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Liquid Phase Concentrated Growth Factor (LPCGF)

What this could lead to

If it works, this could offer a more effective, less invasive option for treating painful jaw clicking and limited mouth opening.

What could go wrong

This is a small, early-stage trial with only 32 participants, so results may not apply to everyone. The treatment is compared to a standard procedure, and benefits may be modest.

Conditions

The condition(s) this trial relates to.

temporomandibular joint disorder temporomandibular joint dysfunction syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.